Skip to main content
Clinical Trials/NCT01219647
NCT01219647
Completed
Phase 1

Exercise as a Strategy to Treat Cognitive Dysfunction in Persons With Multiple Sclerosis

University of California, Los Angeles2 sites in 1 country35 target enrollmentJuly 2010

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Multiple Sclerosis
Sponsor
University of California, Los Angeles
Enrollment
35
Locations
2
Primary Endpoint
Paced Auditory Serial Addition Test (PASAT)
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

Many persons with Multiple Sclerosis ( MS) have problems with memory and thinking.Exercise has been shown to improve memory and thinking in persons with diseases such as Alzheimer's. This study will investigate whether a program of aerobic exercise can improve memory and thinking in persons with MS

Detailed Description

Persons with Multiple Sclerosis(MS)will be screened for eligibility and randomized to a protocol with two intervention arms. One group will have aerobic training on a recumbent cross trainer three times a week for 20-30 minutes/session. The other group will participate in stretching exercises at the same frequency and intensity.Total training time will be six months.Outcome measures will include tests of memory and thinking, and fitness measures.

Registry
clinicaltrials.gov
Start Date
July 2010
End Date
August 2014
Last Updated
11 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Barbara Giesser

Clincial Profesor of Neurology

University of California, Los Angeles

Eligibility Criteria

Inclusion Criteria

  • Clinical Diagnosis of MS Complaints of cognitive problems Able to ride a recumbent cross trainer

Exclusion Criteria

  • Cardiopulmonary or structural disease that would limit ability to participate in exercise training On treatment with chemotherapy or natalizumab Screening score of \>50 on PASAT

Outcomes

Primary Outcomes

Paced Auditory Serial Addition Test (PASAT)

Time Frame: 36 weeks

test of attention and information processing

Secondary Outcomes

  • Symbol Digit Modalities Test (SDMT)(36 weeks)
  • Long latency cognitive event related potentials ( LLCERP)(36 weeks)
  • VO2 max(36 weeks)

Study Sites (2)

Loading locations...

Similar Trials